Metraipolis › archive › dc_79bc67a01a2a

Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials — Europe PMC PMID:42569733

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42569733
DOI
10.7759/cureus.112239
License (as archived)
solo-consultazione
Archived
2026-10-18T10:43:57.802Z
SHA-256 of the archived text
32660d8cc30c034dff3d5fd352863611bc25659b14b8120499f1d5fd69434c36
Stable URL of this page
https://metraipolis.com/documento/dc_79bc67a01a2a

How to cite

Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials — Europe PMC PMID:42569733 — Europe PMC (en), https://europepmc.org/article/MED/42569733 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_79bc67a01a2a (Metraipolis archive dc_79bc67a01a2a, sha256 32660d8cc30c034dff3d5fd352863611bc25659b14b8120499f1d5fd69434c36)
BibTeX
@misc{dc79bc67a01a2a,
  title = {Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials — Europe PMC PMID:42569733},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42569733},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_79bc67a01a2a; sha256 32660d8cc30c034dff3d5fd352863611bc25659b14b8120499f1d5fd69434c36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569733. Agents can read the archived copy with the MCP tool read_document.